Abstract

Brugada syndrome is a disease entity associated with a characteristic electrocardiographic pattern known as the type-1 Brugada electrocardiogram and is associated with an increased risk for supraventricular and, importantly, malignant ventricular arrhythmias. Brugada phenocopy is a description of similar electrocardiographic patterns due to other conditions. The principal difference between the two entities is the absence of a spontaneous type-1 pattern and/or the noninducibility of a type-1 pattern by potent sodium channel blockers in Brugada phenocopy when the initial condition has dissolved. In this chapter, the value of the sodium channel blocker provocation test in Brugada syndrome and Brugada phenocopy is discussed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.